Time of onset of ventilator-associated pneumonia and influence on mortality

International Journal of Intensive Care

Volumn 15, Issue 2, 2008, Pages 52-55

  Ferrer, R ^a   Martinez M L ^a   Vallaes J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

AGE; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BRONCHOSCOPY; COMORBIDITY; ENDOTRACHEAL INTUBATION; HUMAN; INCIDENCE; INFECTION RISK; LOWER RESPIRATORY TRACT INFECTION; LUNG LAVAGE; MORTALITY; PULMONARY ASPIRATION; RISK FACTOR; SUPINE POSITION; TREATMENT DURATION; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 62649140982     PISSN: 13502794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Kollef MH. Epidemiology and risk factors for nosocomial pneumonia. Emphasis on prevention. Clin Chest Med 1999; 20: 653-670.
2. Pingleton SK, Fagon JY, Leeper KV, Jr. Patient selection for clinical investigation of ventilator-associated pneumonia. Criteria for evaluating diagnostic techniques. Chest 1992; 102: 553S-556S.
3. Niederman MS, Bass JB, Jr., Campbell GD, Fein AM, Grossman RF, Mandell LA et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis 1993; 148: 1418-1426.
4. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in medical intensive care units in the United States National Nosocomial Infections Surveillance System. Crit Care Med 1999; 27: 887-892.
5. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH et al. The prevalence of nosocomial infection in intensive care units in Europe Results of the European Prevalence of Infection in Intensive Care (EPIC Study. EPIC International Advisory Committee. JAMA 1995; 274: 639-644
6. Chevret S, Hemmer M, Carlet J, Langer M. Incidence and risk factors of pneumonia acquired in intensive care units. Results from a multicenter prospective study on 996 patients. European Cooperative Group on Nosocomial Pneumonia Intensive Care Med 1993; 19: 256-264.
7. Cavalcanti M, Ferrer M, Ferrer R, Morforte R, Garnacho A, Torres A. Risk and prognostic factors of ventilator-associated pneumonia in trauma patients. Crit Care Med 2006; 34: 1067-1072.
8. George DL, Falk PS, Wunderink RG, Leeper KV, Jr., Meduri GU, Steere EL et al. Epidemiology of ventilator acquired pneumonia based on protected bronchoscopic sampling Am J Respir Crit Care Med 1998; 158: 1839-1847.
9. Kollef MH. The prevention of ventilator-associated pneumonia N Engl J Med 1999: 340: 627-634.
10. Ferrer R, Artigas A. Clinical review: non-antibiotic strategies for preventing ventilator associated pneumonia. Crit Care 2002; 6: 45-51.
11. Levine SA. Niederman MS. The impact of tracheal intubation on host defenses and risks for nosocomial pneumonia. Clin Chest Med 1991; 12: 523-543.
12. Bauer TT, Torres A, Ferrer R, Heyer CM, Schultze-Werninghaus G, Rasche K. Biofilm formation in endotracheal tubes Association between pneumonia and the persistence of pathogens Monaldi Arch Chest Dis 2902; 57: 84-87.
13. Langer M, Mosconi P, Cigada M, Mandelli M. Long-term respiratory support and risk of pneumonia in critically ill patients. Intensive Care Unit Group of Infection Control. Am Rev Respir Dis 1989; 140: 302-305.
14. Torres A. Gatell JM, Aznar E et al. Re-intubation increases the risk of nosocomial pneumonia in patients needing mechanical ventilation. Am J Respir Crit Care Med 1995; 152: 137-141.
15. Johanson WG, Jr., Pierce AK, Sanford JP, Thomas GD. Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract. Ann intern Med 1972; 77: 701-706.
16. Croce MA, Fabian TC, Waddle-Smith L, Melton SM, Minard G, Kudsk KA, et al. Utility of Gram's stain and efficacy of quantitative cultures for posttraumatic pneumonia: a prospective study. Ann Surg 1998; 227: 743-751.
17. Wimberley N, Faling LJ, Bartlett JG. A fiberoptic bronchoscopy technique to obtain uncontaminated lower airway secretions for bacterial culture Am Rev Respir Dis 1979: 119: 337-343.
18. Sanchez-Nieto JM, Torres A, Garcia-Cordoba F et al. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study Am J Respir Crit Care Med 1998: 157: 371-376.
19. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005: 171: 388-416.
20. Crouch BS, Wunderink RG, Jones CB, Leeper KV, Jr. Ventilator-associated pneumonia due to Pseudomonas aeruginosa. Chest 1996; 109: 1019-1029.
21. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU Acquired Pneumonia Study Group. Intensive Care Med 1996; 22: 387-394.
22. Kollef MH, Silver P, Murphy DM, Trovillion E. The effect of late-onset ventilator associated pneumonia in determining patient mortality. Chest 1995; 108: 1655-1662.
23. Ioanas M, Ferrer M, Cavalcanti M et al. Causes and predictors of nonresponse to treatment of intensive care unit-acquired pneumonia. Crit Care Med 2004: 32: 938-945.
24. Rello J, Jubert P, Valles J, Artigas A, Rue M, Niederman MS. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa Clin Infect Dis 1996; 23: 973-978.
25. Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999; 159: 1249-1256.
26. Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospitality stay. Am J Med 1993; 94: 281-288.
27. Ibrahim EH, Ward S, Sherman G, Kollef MH. A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. Chest 2000; 117: 1434-1442.
28. Giantsou E, Liratzopoulos N, Efraimidou E et al. Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria. Intensive Care Med 2005; 31: 1488-1494.
29. Valles J, Pobo A, Garcia-Esquirol O, Mariscal D, Real J, Fernandez R. Excess ICU mortality attributable to ventilator-associated pneumonia: the role of early vs late onset. Intensive Care Med 2007; 33(8: 1363-1368.
30. Moine P, Timsit JF, De Lassence A et al. Mortality associated with late onset pneumonia in the intensive care unit: results of a multi-center cohort study. Intensive Care Med 2002: 28: 154-163.